These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 31672340)
1. Complement and Coagulation: Cross Talk Through Time. Dzik S Transfus Med Rev; 2019 Oct; 33(4):199-206. PubMed ID: 31672340 [TBL] [Abstract][Full Text] [Related]
2. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992 [TBL] [Abstract][Full Text] [Related]
3. The Activation of Complement and Its Role in the Pathogenesis of Thromboembolism. Boyce S; Eren E; Lwaleed BA; Kazmi RS Semin Thromb Hemost; 2015 Sep; 41(6):665-72. PubMed ID: 26305235 [TBL] [Abstract][Full Text] [Related]
11. Complement in hemolytic anemia. Brodsky RA Hematology Am Soc Hematol Educ Program; 2015; 2015():385-91. PubMed ID: 26637747 [TBL] [Abstract][Full Text] [Related]
12. Reincarnation of ancient links between coagulation and complement. Conway EM J Thromb Haemost; 2015 Jun; 13 Suppl 1():S121-32. PubMed ID: 26149013 [TBL] [Abstract][Full Text] [Related]
13. The control of complement activation by the blood cells in paroxysmal nocturnal hemoglobinuria. Rosse WF Blood; 1986 Feb; 67(2):268-9. PubMed ID: 2417643 [No Abstract] [Full Text] [Related]
14. Complement the hemostatic system: an intimate relationship. Weitz IC Thromb Res; 2014 May; 133 Suppl 2():S117-21. PubMed ID: 24862131 [TBL] [Abstract][Full Text] [Related]
16. A review of the alternative pathway of complement and its relation to HELLP syndrome: is it time to consider HELLP syndrome a disease of the alternative pathway. Vaught AJ; Braunstein E; Chaturvedi S; Blakemore K; Brodsky RA J Matern Fetal Neonatal Med; 2022 Apr; 35(7):1392-1400. PubMed ID: 32338085 [TBL] [Abstract][Full Text] [Related]
17. Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies. Zarantonello A; Pedersen H; Laursen NS; Andersen GR Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671302 [TBL] [Abstract][Full Text] [Related]
18. Current and future pharmacologic complement inhibitors. Risitano AM Hematol Oncol Clin North Am; 2015 Jun; 29(3):561-82. PubMed ID: 26043392 [TBL] [Abstract][Full Text] [Related]
19. Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics. Patriquin CJ; Kuo KHM Transfus Med Rev; 2019 Oct; 33(4):256-265. PubMed ID: 31703946 [TBL] [Abstract][Full Text] [Related]
20. Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology. Zuckerman R; Asif A; Costanzo EJ; Vachharajani T J Bras Nefrol; 2018; 40(1):77-81. PubMed ID: 29796581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]